Introduction
Gm, gangliosidosis is an autosomal recessive disorder which occurs in at least two distinct clinical phenotypes [2, 91. In Gm, gangliosidosis type I, hepatosplenomegaly, alveolar ridge hypertrophy, and severe bony deformities are usually evident at birth. Progressive psychomotor retardation is evident and death usually occurs within the first 2 years. In contrast, Gm, gangliosidosis type II is usually detected at approximately 1 year of age when psychomotor retardation and hypotonia are evident and death occurs between 3 and 10 years of age. Gm, ganglioside accumulates in neural and visceral tissues in type I, patients and in brain in type II patients. The enzymatic basis for the accumulation of Gm, ganglioside in both types has been related to a deficiency in the activity of p-galactosidase [12] , an enzyme which normally hydrolyzes the terminal galactose from Gm, ganglioside.
Several investigators have attempted to elucidate the relationship between the two types of Gm, gangliosidosis on the basis of the properties of the residual pgalactosidase activity. Pinsky and Powell [13] noted differences in pH optima and thermostability of the residual p-galactosidase activity in cultured skin fibroblasts from type I and type 11 patients. On the basis of this finding, they suggested that type I and type II Gml gangliosidosis are separate genetic diseases. In contrast, Singer and Schafer [14] found that although different degrees of accumulation of Gm, gangliosides could be demonstrated in the liver of patients with type I and type 11 Gml gangliosidosis, the properties of the residual p-galactosidase were similar. They inter-preted their findings to indicate that a mutation at the same locus was responsible for these disorders.
In order to elucidate the nature of mutation(s) in type I and type II Gm, gangliosidosis, we have compared the residual p-galactosidase in brain tissue of patients with these two clinical phenotypes in which the amount of accumulated Gm, ganglioside has been shown to be similar [16] . Despite this similarity in the quantity of cerebral Gm, ganglioside accumulated, the residual brain p-galactosidases in patients with type I and type I1 Gm, gangliosidosis were found to differ in their thermostability and electrophoretic mobility.
Materials and Methods

Specimens
Brain was obtained from a 21-week-old fetus in whom the diagnosis of Gm, gangliosidosis type I I was established on the basis of an absence of p-galactosidase activity in amniotic fluid, fibroblasts, and organs of the fetus. The pregnancy was monitored as the parents had previously given birth to a child with Gml gangliosidosis type Il. Samples of brain obtained postmortem from patients with Gml gangliosidosis type I were kindly provided by Dr. John O'Brien and Dr. James Lowden. Control fetal and postnatal brains were obtained either immediately postmortem or after termination of pregnancy for social reasons. All samples were kept at -70" until preparation of homogenates.
Assay of p-Galactosidase
Brain tissue was homogenized in distilled water using a Teflon-glass homogenizer with 7-8 strokes at OO.
The homogenate was then centrifuged at 100,000 x g for 30 min at 4", and the supernatant used for enzyme assay. The protein concentration of the supernatant was determined by the method of Lowry et al. [8] .
The reaction mixture (0. 
Gel Electrophoresis
A sheet of Sepraphore [I91 was wetted with 0.05 n~ sodium citrate-citric acid buffer, pH 5.5. A 5-p1 aliquot of supernatant was applied in the middle of the sheet. The separation was carried out at room temperature at a constant current of 10 ma/sheet for 3.5 hr and a voltage of approximately 100. Vertical starch gel electrophoresis was carried out by the method of Smithies [Is] . Thirteen percent starch gel was prepared in 5 mM sodium phosphate buffer, pH 7.0. A 50-p1 sample was applied in each slot. The electrophoresis was carried out at 4" with a constant voltage of 160 V for 16 hr .
At the end of electrophoresis, the gel was covered by a piece of Whatman filter paper saturated with a reaction mixture containing 0.17 mg/ml of 4-methylumbelliferyI-p-D-galactopyranoside in 0.1 M sodium phosphate-citric acid buffer, pH 3.7. After incubation at 37" for 1 hr, the gel was covered by a piece of Whatman filter paper saturated with 0.2 M glycine-NaOH buffer, pH 10.2. The pattern of fluorescence on the gel was photographed immediately.
Results
The initial experiment was designed to examine the effect of pH upon the p-galactosidase activity in brain extracts. Figure 1 compares the pH activity curves of p- T h e quantitative comparison of the enzyme activity at p H 3 and 4 of all the specimens studied is shown in Table I . At p H 3, both fetal and postnatal control subjects had about the same level of enzyme activity. At this pH, p-galactosidase activity in the brains of children with type d and the fetus with type II Gm, gangliosidosis was reduced to approximately 27% of the control values. At p H 4, the enzyme activities in the control children were about twofold higher than that in the control fetus and the activities in both type I and type I I patients were reduced to approximately 6% of the activities in the control subjects.
T h e thermostability of p-galactosidase was examined by preincubating the brain extracts at 42" for various lengths of time and the activity was measured at both p H 3 and 4. Figure 2a indicates that the enzyme activity at p H 3 from patients with either type of Gm, gangliosidosis was more thermostable than that of control subjects. T h e inactivation rate of p-galactosidase from the type II patient was intermediate between those of control and type I patients. When the enzyme was assayed at p H 4 after preincubation at 42" for 2 hr (Fig.  2b) , 100% of the p-galactosidase activity from the type I I patient remained, whereas 70% of the enzyme activity from the type I patient and 10% of that froin the control subjects remained.
T h e electrophoretic patterns on Sepraphore of supernatants obtained from brain homogenates and incubated with 4-methylumbelliferyl-p-D-galactopyranoside are shown in Figure 3 . A 5-,~1 (10-20 pg protein) sample from the supernatant was used as described by Fluharty et al. [3] . At least two p-galactosidase bands were found by this method in brain homogenates from the control fetus, control child (not shown) and child with type I disease. T h e band which migrated towards the ariode was completely absent in the brain of the fetus with type II, disease, whereas the p-galactosidase which did not migrate from the origin was readily visible. I t was also noted that the mobility of the band which migrated towards the anode in the brain of the r , , , , , , l Residual enzyme activity after preincubation at 42" is expressed as a percentage of the activity without preincubation.
control fetus was greater than that in the brain of the type patient.
+
Electrophoresis of brain p-galactosidase was repeated by using starch gel. T h e result is shown in Figure 4 . There were at least two distinguishable bands with identical mobility in the brains from both control fetus and child. I n the brain of type I patients, the mobility of the migrating isozyme was different from Odgln that in the control subjects. T h e absence of the migrating p-galactosidase isozyme in the brain of the type 11 patient was also clearly demonstrated.
These data demonstrate differences in the p H optimum, thermostability, and electrophoretic mobility of brain p-galactosidases obtained from patients with Gm, gangliosidosis type I and tyfie II; and control subjects. p-Galactosidase from normal human brain has a broad p H activity curve with maximal activity at p H 4 in citrate-phosphate buffer. This is consistent with previous studies which utilize purified p-galactosidase from rabbit brain [5] . I n contrast, the p H optimum of the enzyme from the brain of patients with either type I or type II Gm, gangliosidosis was 3. Pinsky and Powell [13] have shown that the p-galactosidase in skin fibroblasts cultured from a type I patient had a p H optimum of 3.5, which was different from the p H optimum of 4.5 for that in control fibroblasts and fibroblasts from type I I patients. T h e p H optimum of liver p-galactosidase in patients with type I and type ZI, Gm, gangliosidosis was 6-7 as compared with control values of 3 . 6 4 [lo, 123. One possible explanation for these changes of p H optimum in patients with Gm, gangliosidosis is the absence of one or more of the multiple isozymes which have different p H optima under similar assay conditions. Although the p H optima of brain p-galactosidase in both type I and type 11 patients were similar, difference i n the p H dependence was observed (Fig. 1) . T h e p-galactosidase activity of type I I patients was less than that of type I patients when the p H of the reaction mixture was between 3 and 5. I t is possible that either there is less enzyme activity at pH values between 3 and 5 in the brain of type 11 patients or it may simply reflect the difference between fetal and postnatal enzyme.
Differences in thermostability among p-galactosidase isoaymes have been demonstrated in human liver [4] and skin fibroblasts 1131. This was also observed in type Gm, gangliosidosis were relatively thermostable. T h e p-galactosidase activity assayed at p H 4 in the brain of the type II fetus was extremely stable at 42" and clearly different from that in type I patients and control subjects. T h e difference in thermostability of p-galactosidase between control subjects, type I and type II patients was also observed when assayed at p H 3. This suggests that the residual p-galactosidases in the brain of patients with these two types of Gm, gangliosidosis are actually different. Previous studies in human brain and rabbit brain [5, 61 revealed three p-galactosidase isozymes, two of which migrate towards the anode; one does not migrate from the origin and is thought to be particlebound [3] . I n our study, two p-galactosidase bands were preseni on both cellufose acetate and starch gel after electrophoresis. These differences are probably due to different electrophoretic methods.
Kaback et al. [6] have shown that there was a single band which did not migrate from the origin in the brain of a fetus with type I Gm, gangliosidosis. T h e nonmigrating band was observed in all the specimens studied in this paper. I n addition to this band, brains from type I patients, but not from type patients, had a band which migrated towards the anode and differed in its mobility from that in control subjects. One may argue, at this point, that the difference in the electrophoretic patterns of the brain P-galactosidase between the type I children and the type II fetus could be the result of changes in the isozymes during development. Nevertheless, we observed the difference in the ratio of the activity of the migrating to that of the nonmigrating band between the enzymes from fetal and postnatal brains. I n spite of this difference, the pgalactosidase patterns on starch gel were similar i n the brain of the fetus and children.
As has been found in human liver [I21 and skin fibroblasts [13] , there was a severe deficiency of pgalactosidase activity in the brains from patients with either type of Gm, gangliosidosis. By using 4-methylumbelliferyl-p-galactopyranoside as substrate, the pgalactosidase activity at p H 3 in the brains of type I and type II patients was 27% of the control values, whereas the residual enzyme activity at p H 4 was 6% of the control values. This value is higher in comparison with the finding that 2% of the normal activity was found in the brain from a saline-aborted fetus with type I Gm, gangliosidosis when assayed at p H 4.5 with o-nitrophenyl-p-D-galactoside as substrate [6] . T h e difference between the residual p H 3 and p H 4 enzyme activity in the patients suggests that the mutation may have a selective effect on one or more of the isozymes. I n addition, brain p-galactosidase appears to be distinct from the liver enzyme [4] , inasmuch as no effect of chloride ions was noted at any of the p H values assayed.
Recently, Kint et al. [7] reported an abnormal distribution of a number of lysosomal isozymes, including p-galactosidase, in liver of the patients with mucopolysaccharidoses. T h e isozyme abnormalities could be reproduced in uitro by addition of chondroitin sulfate to a homogenate of normal liver. After the addition of chondroitin sulfate, the total activity of p-galactosidase is inhibited, whereas other hydrolases are affected only slightly or not at all. One might speculate that the "keratosulfate-like" material which accumulates in the visceral tissues of patients with Gm, gangliosidosis [I] might produce similar effects on p-galactosidase. I t should be pointed out that P-galactosidase activity was assayed in our study as well as in previously reported studies by using synthetic substrate, and may or may not represent the Gm, gangliosidase activity. Further studies utilizing the natural substrate, Gm, ganglioside, will be necessary to clarify this problem. On the basis of these results, we suggest that the two clinical phenotypes of Gml gangliosidosis are determined by mutational events which occur either at different loci of a gene or at different genes. I n addition, both disorders appear to be the result of structural gene mutations.
Sumnzary
Several properties of p-galactosidase obtained from brains of control subjects and patients with Gm, gangliosidosis type I and type II were studied. p-Galactosidase from brains of control subjects had a p H optimum of 4, whereas the brain enzyme of patients with either type of Gm, gangliosidosis had a p H optimum of 3. T h e residual p-galactosidase activity in brains of both type I and type II patients was approximately 27% and 6% of the control values when assayed at p H 3 and 4, respectively. Differences in the thermostability of p-galactosidase in control, type I, and type II patients were observed. On both cellulose acetate and starch gel electrophoresis, brains from type I patients, but not from type II patients, had a p-galactosidase band which migrated towards the anode with a mobility different from that of control subjects. We suggest that the two clinical phenotypes of Gm, gangliosidosis are determined by mutational events which occur either at different loci of a gene or at different genes.
